Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inferring the true number of SARS-CoV-2 infections in Japan.
McKenzie L, Shoukat A, Wong KO, Itahashi K, Yasuda E, Demarsh A, Khan K. McKenzie L, et al. J Infect Chemother. 2022 Nov;28(11):1519-1522. doi: 10.1016/j.jiac.2022.08.002. Epub 2022 Aug 9. J Infect Chemother. 2022. PMID: 35961504 Free PMC article.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
COVID-19 postacute care major organ damage: a systematic review.
Greer N, Bart B, Billington CJ, Diem SJ, Ensrud KE, Kaka A, Klein M, Melzer AC, Reule S, Shaukat A, Sheets K, Starks J, Vardeny O, McKenzie L, Stroebel B, Macdonald R, Sowerby K, Duan-Porter W, Wilt TJ. Greer N, et al. Among authors: mckenzie l. BMJ Open. 2022 Aug 24;12(8):e061245. doi: 10.1136/bmjopen-2022-061245. BMJ Open. 2022. PMID: 36002211 Free PMC article.
Evidence Review-Social Determinants of Health for Veterans.
Duan-Porter W, Martinson BC, Greer N, Taylor BC, Ullman K, McKenzie L, Rosebush C, MacDonald R, Falde S, Wilt TJ. Duan-Porter W, et al. Among authors: mckenzie l. J Gen Intern Med. 2018 Oct;33(10):1785-1795. doi: 10.1007/s11606-018-4566-8. Epub 2018 Jul 20. J Gen Intern Med. 2018. PMID: 30030735 Free PMC article. Review.
402 results